Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Duros sufentanil: Began Phase II trial

Durect Corp. (DRRX), Cupertino, Calif.
Product: Duros sufentanil
Business: Neurological

Read the full 103 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE